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Non-medical treatment of first epileptic seizures in 
adolescence and adulthood 
PETER WOLF 
Klinik Mara 1, Epilepsie-Zentrum Bethel, Maraweg 21, 33617 Bielefeld, Germany 
Preliminary results are presented ofa prospective study of patients who after a first seizure were treated by 
avoidance of seizure-precipitating factors. Thirty patients have been enrolled of whom 13 (43.3%) already had 
had a relapse before study onset. Twenty-three patients have been followed for 12 to 102 months, and of these a 
total of 7 relapses were observed. The recurrence rate in the first year of follow-up was 17.4%, much below the 
rate expected from the previously observed relapses. Mostly, the relapses were caused bythe same precipitat- 
ing factors as before. The risk of relapse was not influenced by drug treatment, electroencephalogram findings, 
focal signs, and positive antecedents, but there was a non-significant trend of previous relapses to increase this 
risk. The observed seizure recurrences with antiepileptic drug treatment indicate that, if drugs are prescribed, 
a careful choice of medication is necessary even after a single seizure, and low-dose therapy may not be 
sufficient. However, careful evaluation of individual factors precipitating the first seizure(s), and Careful 
subsequent avoidance ofthese factors eems to be a more efficient therapeutic strategy than pharmacotherapy. 
Key words: First seizures; non-medical treatment; precipitating factors; therapeutic strategies; onset of epi- 
lepsy. 
INTRODUCTION 
Various recent studies have shown that, after a 
first epileptic seizure in adolescents and adults, 
recurrences are more frequent than previously 
believed. The question whether antiepileptic 
drug (AED) treatment should always be given 
following a single seizure is therefore being 
actively debated. Attempts have been made to 
define patients with higher and with lower 
risks of recurrence: one study 1 recommended 
AED treatment if the electroencephalogram 
(EEG) showed epileptiform discharge. 
Several studies were able to compare medi- 
cated and unmedicated groups of patients. 
Annegers et al. 2 reported a cohort of 424 
patients of whom 60.6% were prescribed rugs. 
The risk of seizure recurrence was equal for 
medicated and unmedicated patients after 1 
year both for idiopathic (29 vs. 25%) and 
remote symptomatic (61 vs. 50%) cases, 
whereas after 5 years the idiopathic patients 
were at a higher risk of recurrence when drugs 
had been prescribed (60 vs. 41%; remote symp- 
tomatic patients: 80 vs. 76%). In the study of 
Hopkins et al. 3, AEDs were prescribed to 41 of 
306 adults with first seizures, and no drugs 
given to 265. Both groups did not differ signifi- 
cantly in the rate of recurrence. 
Hauser et al. 4 followed 208 patients of whom 
80% were recommended continuous AEDs. 
These showed a modest but non-significant in- 
crease in recurrence risk compared with the 
untreated patients. However, more in keeping 
with expectations, Hart et al. 5 found a slightly 
reduced recurrence risk in those 15% of a total 
of 564 patients who received drug treatment 
after a first seizure. In all these studies, the 
decision for or against medication was left to 
doctors in charge and not influenced by the 
investigators. In a randomized multicentre 
trial 6 comparing medicated and non-medicated 
patients, however, medication reduced the risk 
of relapse from 41 to 17% after 1, and from 51 
to 25% after 2 years of follow-up. The overall 
relapse rate in this study is considerably ower 
than in the British investigations, probably 
because the purpose of the study required ex- 
clusion of patients with a seizure relapse before 
their first clinical interview, a group with a 
particularly high risk of recurrence 7. 
There are several reasons why the prescrip- 
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tion of AEDs after a single seizure may not be 
as effective in preventing recurrences as the 
prescribing physician probably expects. Ex- 
perience does not teach us the right dose or the 
correct plasma level. A priori, one would tend 
to prescribe a low rather than a high dose in 
order to not expose the patient to unnecessary 
unwanted effects. Would patients after a single 
seizure be more likely to belong to the groups 
which respond to a small AED dose? This, how- 
ever, may be an incorrect assumption. It may 
also be difficult to establish AED compliance 
with somebody who has lust once blacked out'. 
In the studies, successful prevention of recur- 
rences in some cases may be outweighed by 
withdrawal seizures due to non-compliance in
others. In one prospective study 6, 41 of 204 
medicated patients (20%) discontinued medi- 
cation on their own accord, and 11 of them 
(27%) had a relapse. Finally, the choice of drug 
after a first seizure can be difficult, and may 
turn out to have been wrong. 
Can we do better than this? Are drugs the 
only possible means of preventing further seiz- 
ures? 
The question of what provokes the first 
seizure is not uniformly dealt with in the 
literature. Some studies exclude all provoked 
seizures, others some, still others none. More 
importantly, there is no uniform definition of 
seizure provocation. Seizures occurring 'in the 
context of uncertain precipitants uch as sleep 
deprivation or "stress" were considered unpro- 
voked' by Hauser et al. 4 
Others -l° consider lack of sleep as a potent 
and common seizure precipitant. Even if we 
have not yet discovered many of the provoking 
factors, some epileptologists are prepared to 
accept hat provocation of seizures may be the 
rule H. If a seizure precipitant has been identi- 
fied, an attempt can be made to avoid it in 
the future. This does not only apply to first 
seizures, and has indeed long been a central 
part of the counselling we give patients with 
epilepsy. Recently, we have begun to apply this 
in a more uniform way with all patients who 
are seen after a first seizure, and to follow them 
prospectively. 
This paper reports preliminary results of 
this longitudinal study. 
PATIENTS AND METHODS 
In this study, all patients were included who 
made an appointment following a first clearly 
and unmistakenly described epileptic seizure, 
the 'index seizure' of this study. This was not 
necessarily the only seizure the patient had 
had. In some, the first observation of a well- 
described seizure clarified an earlier event 
which had remained undiagnosed. Others had 
suffered recurrences between the index seizure 
and the first interview at the clinic. They were 
all included. The only exclusion criteria was 
if neurological and ancillary investigations 
revealed a progressive or acute symptomatic 
aetiology including chronic alcohol or sub- 
stance abuse. 
The patients in this study are not an 
unbiased group. Patients with first seizures 
usually do not come to a fourth level epilepsy 
centre although some of the patients in this 
study were recruited from our emergency 
room. The majority were transferred from their 
physicians or came by themselves for a second 
opinion about the diagnosis, the necessity to 
take drugs, or their ability to drive. 
Great care was taken to exclude the possi- 
bility that the patients already had epilepsy, 
and that the apparent first seizure was only the 
first obvious seizure. This included history 
taking with specific questions about some of 
the more common auras and of myoclonicjerks. 
If a patient's EEG presented generalized Spike 
Wave (SW) activity, a video EEG was per- 
formed with tests of responsiveness during SW 
activity. I have not counted these instances 
but, as a rough estimate, for about every two 
patients included in the study there was one 
with a presumed first seizure who had to be 
excluded because he or she clearly already suf- 
fered from unrecognized but established epi- 
lepsy. 
On 30 June 1994, the study comprised a 
total of 30 patients (Table 1) who have been 
followed for an average of 30.4 months (range 
2-102). 
The first interview with these patients and, 
if possible, their relatives was extensive. It 
included a detailed analysis of the immediate 
situation in which the seizure(s) had occurred, 
and of the days and weeks preceding the seiz- 
ure. The purpose of this was to discover specific 
seizure precipitating factors such as flashing 
lights, as well as non-specific provocants uch 
as sleep withdrawal, important life events and 
all factors which the patients believed to have 
contributed to the seizure. In every case, an 
attempt was made to reach a hypothesis ac- 
ceptable to both patient and doctor on what 
had provoked the seizure. Frequently, the 
patients and relatives would suggest 'stress' as 
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Table 1 : Patient overview (n = 30) 
Sex 
Males 
Females 
Age at entry (years; median with range) 
0-10 
11-20 
21-30 
>30 
Length of follow-up (months; median with range} 
16 
14 
24.0 
(10-51) 
1 
12 
13 
4 
30.4 
(2-102} 
> 12 months ince index seizure: 23 
Antecedents 
Perinatal brain damage 5 
Febrile convulsions 3 
Benign childhood epilepsy (centro-temporal) 1 
Brain trauma 1 
Seizure types 
Primarily generalized tonic-clonic (TC) 10 
Focal --, generalized TC 6 
Absence series ~ generalized TC 1 
Generalized clonic (conscious) --, TC 1 
Generalized TC, unspecified 8 
Complex focal 2 
Absence status 1 
Unclassified 1 
Number of seizures before study 
(43.3% relapses before study onset) 
1 17 
2 10 
3 2 
4 1 
Epileptiform EEG 
Yes 15 
Photosensitive 7 
Focal 4 
No 15 
Antiepileptic drugs at entry 
Yes 12 
Now without 5 
Change of drug after relapse 2 
No 18 
Now on drugs 2 
the cause of the seizure. This was only accepted 
in case of convincingly defined situations of 
quite unusual physical or psychic strain. Table 
2 sums up all precipitating factors thus identi- 
fied. The total number is higher than 30 
because, frequently, more than one factor was 
present. There was only one patient with no 
convincing provocation whatsoever. 
All patients received detailed counselling 
following a semi-structured schema where the 
following points were made clear: 
- -  The event was an epileptic seizure 
- -  A single seizure does not yet mean that the 
diagnosis is 'epilepsy' 
- -  It means, however, that there is a high risk 
that epilepsy will develop unless substan- 
tial countermeasures are taken. I usually 
Table 2: Precipitating factors 
89 
Disturbance of sleep-waking cycle 26 
Extraordinary stress 6 
Intermittent lights 4 
Television 2 
Increased alcohol intake 3 
Hunger, hypoglycemia 2 
Fever 2 
Migraine 1 
Sunstroke 1 
Specific movement 1 
None 1 
point out to the patient that this is most 
probably a life-long risk 
- -  Every single additional seizure is a step to- 
wards the development ofepilepy and must, 
therefore, be prevented 
- -  The seizure means temporary unfitness for 
driving 
The patients were informed about antiepileptic 
drug treatment (its minimal duration and the 
necessity of strictly regular intake of drugs; 
their effectiveness, safety, and possible un- 
toward effects). The patients were invited to 
make their own decision for or against drug 
treatment. If they asked for advice it was 
usually suggested that they continued medi- 
cation if they were already taking some, and 
not to start if they were not already taking it. 
As a consequence of the individual hypoth- 
esis about seizure precipitation (see above), 
strategies for its future avoidance were dis- 
cussed in detail. These always included regular 
sleep-wake habits, and cautious use of, or 
abstinence from, alcohol. 
The main points of advice were summed up 
in a memo 12 which was given to the patients 
who were requested to take it home to read and 
come back with any additional questions which 
might arise. During follow-up, patients were 
seen as out-patients at individually deter- 
mined intervals. Usually, there were two to 
four interviews in the first year and one to two 
in the following years. 
RESULTS 
Of the total of 30 patients who have been 
enrolled until 30 June 1994, 23 have been fol- 
lowed for over 1 year, and their results are 
reported. Seven have so far had a relapse 
(Table 3). The relapse rate in the first year of 
follow-up was 4 of 23 (17.4%), much lower than 
the retrospective relapse rate of 47.8% in the 
90 P. Wolf 
same patients. Three relapses occurred in the 
second, third, and ninth year of follow-up. 
In four cases, the relapse consisted of a single 
seizure. Twenty patients (87%) were seizure 
free for more than 12 months at their last visit. 
Relapses were not related to any of the 
following factors: antiepileptic drug treatment; 
epileptiform EEG discharge; known ante- 
cedents; or focal signs in seizure semiology or 
EEG. There was a non-significant trend to an 
increased risk for relapse if there had been pre- 
vious relapses (Table 3). 
All relapses but one were again caused by 
provocative factors, usually the same as the 
previous one (Table 4). 
A total of 11 patients had been prescribed 
drugs before the start of the study. Five had 
received valproic acid (VPA), and were still on 
it. Four had received carbamazepine (CBZ), 
and two were still on it whereas one had been 
switched to VPA because with CBZ he was 
photosensitive with generalized SW. The last 
patient put on CBZ was switched to phenytoin 
(DPH) following a severe allergic reaction. One 
patient had been given DPH which, after a 
seizure relapse during intermittent light 
stimulation in the EEG at a serum level of 
8.6 I~g/ml was changed to VPA which had to be 
discontinued because she developed severe alo- 
pecia and tremor (plasma levels unknown). 
One patient had received treatment with an 
unknown drug abroad following her first seiz- 
ure, and this was discontinued after an allergic 
reaction. Thus, of a total of 14 previous medi- 
cations, three had to be abandoned due to 
unwanted effects, and two choices had been 
inappropriate. 
Of the 11 patients who had been prescribed 
drugs, two decided against medication, and 
had no seizure recurrence. Nine decided for 
medication. Three relapses occurred in spite of 
drug therapy, and none of them were due to 
non-compliance with the medication. 
Patient 1 
A 21-year-old male was treated with CBZ after 
two idiopathic non-focal generalized tonic- 
clonic (GTC) seizures both precipitated by 
reduced sleep, with no EEG abnormalities 
even in multichannel 48-hour monitoring. In 
the second year of follow-up, a third GTC seiz- 
ure occurred uring a febrile respiratory infec- 
tion. The postictal CBZ level of 3.9 i~g/ml was 
Table 3: Relapses (n = 7 of 23) 
Relapse rate 
Before entry 11 (47.8%) 
In first follow-up year 4 (17.4%) 
Influence of drug treatment? 
Untreated 3 of 14 
Treated 4 of 9* 
Influence of EEG findings? 
Epileptiform EEG 4 of 13 
No epileptiform EEG 3 of 10 
Influence of antecedents? 
Antecedents 1 of 7 
No antecedents 6 of 16 
Influence of focal signs (in seizure semiology or EEG)? 
Focal signs 3 of 8 
No focal signs 4 of 15 
Influence of previous relapses? 
Previous relapse(s) 5 of 11 
No previous relapses 2 of 12 
* 3 patients with drug therapy, 1 patient one year after 
discontinuation of7-year drug therapy. 
Table 4: Causative factors of seizure relapse 
Disturbance of sleep-waking cycle 
Extraordinary stress 
Fever 
Wrong selection of drug 
Precipitation by video game 
Development ofjuvenile absence pilepsy 
only slightly below his habitual evels of about 
5 txg/ml. A post-ictal EEG revealed abundant 
generalized spike-wave discharges. Medication 
was changed to VPA, and he has now been 
seizure free for 21 months. 
Patient 2 
A 22-year-old female had two cryptogenic GTC 
seizures with an indistinct aura 5 days apart in 
a phase of insomnia due to serious probi.ms 
with her job. EEGs and imaging studies were 
unrevealing. She was treated with DPH at 
serum levels of 8-9 ixg/ml. Three months later, 
she had another GTC seizure with an aphasic 
aura when her husband had left her because of 
the seizures, and she again became sleepless. 
Her post-ictal DPH level was 8.6 txg/ml. DPH 
was increased to levels of 17-20t~g/ml. 
Because of ongoing psychological problems he 
was advised to start psychotherapy (for a 
detailed history see Wolf12). She has now been 
seizure free for 2.5 years, still on the same dose 
of DPH. 
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Patient 3 
A 30-year-old male with a past history of 
febrile convulsions was treated with VPA 
(plasma levels of 60-80 ~g/ml) after he had 
had, 1 month apart, two primarily generalized 
TCS during sleep at the end of 2 months with a 
heavily increased work load, lack of sleep, and 
too much alcohol. His EEG was normal. More 
than 2 years later, he had a complex focal seiz- 
ure with oral automatisms described by his 
wife, after a quarrel and a night of disturbed 
sleep. Drug intake had been regular, counter- 
checked by his wife. His treatment was 
changed to CBZ, and he has now been free of 
seizures for 8 months. 
In five of nine patients who were on a drug at 
study onset, the drug was discontinued after 
periods of 4 months to 2 years and, in one 
patient, after 7 years. Only one of these 
patients had a relapse. 
Patient 4 
This 19-year-old male, a fire brigade volunteer, 
had a twilight state probably caused by ab- 
sence status, at the end of a long night of fire 
fighting. His EEG presented generalized SW 
discharges, and he was put on VPA. This treat- 
ment was reduced very slowly over 7 years 
because of repeated SW increase after dose re- 
ductions. One year after discontinuation of
VPA, he had his second, very similar seizure 
when he participated, against my advice, for 
the second time again in a night's fire fighting. 
We agreed not to re-start drug treatment but to 
rely again on sleep regulation. He has re- 
mained seizure free since. 
Of the 14 patients who were not treated with 
drugs, three had a relapse, and drug treatment 
was started in two of them. 
Patient 5 
A 29-year-old female saw me after her third 
primarily generalized TCS in 1.5 years. At the 
two previous occasions, the diagnosis had re- 
mained open due to insufficient observation, 
and she was undergoing psychotherapy 
because a psychogenic problem had been 
assumed. All seizures had been preceded by 
lack of sleep, and one occurred uring a heated 
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telephone conversation with her mother. She 
has generalized SW discharges on her EEG. 
She decided against drug treatment but proved 
unable to avoid sleep withdrawal due to her 
neurotic problems (she is still undergoing 
psychotherapy). Drug treatment was begun 
after her seventh seizure. 
Patient 6 
A 10-year-old girl, the only child in the cohort, 
whose mother is under my treatment for a 
benign cryptogenic focal epilepsy starting as 
an adult. She is the only patient where no pre- 
cipitating factors could be discovered for both 
her GTCS which occurred at an interval of 3 
months. Whereas detailed investigations after 
the first seizure had revealed photosensitivity 
on the EEG as the only abnormality, reinvesti- 
gation after the second seizure discovered ab- 
sences with impaired consciousness and very 
mild eyelid myoclonus which she did not  
notice, and which had never been observed. 
Thus, here, the first and definitely unprovoked 
GTC seizure marked the onset of juvenile ab- 
sence epilepsy. The patient was treated with 
VPA 300 mg (serum levels 20-25 ~g/ml), and 
has been seizure free with normalized EEG for 
2.5 years. 
Patient 7 
An 18-year-old female was seen after two cryp- 
togenic GTC seizures with an interval of 8 
months, both preceded by lack of sleep. Her 
EEG showed generalized SW, and right tem- 
poral sharp waves. Her third seizure occurred 
11 months later during a video game, in the 
absence of other provocative factors. A fourth 
seizure, 3months later, was again precipitated 
by an extraordinarily massive sleep with- 
drawal. She still declined drug therapy, 
became very sleep disciplined and has now 
been seizure free for 16 months. 
DISCUSSION 
The patient group studied here is small enough 
to keep track of every patient, and analyse the 
emerging questions in individual detail when- 
ever this is desirable. But it is also prospective 
and almost big enough for group analysis, and 
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for at least a tentative comparison with other 
studies. The study is not controlled for the 
obvious reason that in this type of intervention 
no placebo is conceivable. However, a retro- 
spective comparison is possible because there 
was always some delay between the index seiz- 
ure and enlisting in the study, and patients 
with recurrences before study onset but after 
the index seizure were not excluded. 
The retrospective relapse rate of these 
patients was 47.8% (i.e. between the first seiz- 
ure and enrolment in the study), and the spon- 
taneous prospective relapse rate (i.e. after 
enrolment in the study) would have been 
expected to increase rather than decrease. 
Instead, the rate of relapse fell to 17.4% in the 
first year of follow-up, after enrolment in the 
study, which is among the lowest reported in 
literature. Although a trend towards a higher 
risk of relapse was noted if the patient had 
experienced more than one seizure, there was, 
thus, a considerable overall decrease of risk 
which can only be ascribed to the non- 
pharmacological therapy reported here 
because this was the only consistent interven- 
tion. Drug therapy, EEG findings, historical 
data, and focal signs all had no influence on the 
relapse rate. This is at variance with the find- 
ings of van Donselaar et al. 1 who found that the 
risk of relapse was twice as high if their 
patients had epileptiform activity in their 
EEGs compared with those that had not. How- 
ever, it is not sufficiently clear if this always 
was subclinical discharge, and that study may 
easily have included patients with their first 
GTC but chronic non-convulsive seizures. The 
latter can be extremely difficult to rule out. 
Our findings concerning drugs are in accord 
with the part of the literature which reports no 
influence of AED treatment on the prognosis 
after first seizures z-4 whereas other authors 
found such a difference ~'6. Only in the Italian 
collaborative study of first tonic-clonic seiz- 
ures 6 were the results with medication equally 
as favourable as here. However, that study 
only comprised 21% with remote previous eiz- 
ures, and none with recurrences between index 
seizure and first interview, so that a better 
prognosis than in our group could have been 
expected. That study is otherwise difficult to 
compare with the present one because one 
third of the study population were children 
who had relapses more frequently but were not 
analysed separately. The authors also make it 
clear that they could not reliably exclude the 
possibility of preceding or ongoing non- 
convulsive seizures, which may account in part 
for the higher relapse rate they found in 
untreated patients. 
In the majority of studies, the relapse rate in 
patients treated with drugs is alarmingly high, 
much higher than in many common epilepsy 
syndromes, and needs an explanation. Unlike 
in patients with established epilepsy where 
drug treatment may be titrated against seizure 
recurrence, after a first seizure it is of para- 
mount importance that any additional seizures 
are avoided if possible. 
The first of three probable reasons why drug 
treatment after a first seizure is less effective 
than desired is the lack of clues about the 
adequate dose or serum level needed. Prima 
facie, it might be expected that these patients 
would respond to low levels because they have 
had so few seizures. However, it is not known 
whether the total number of seizures is a factor 
related to individual therapeutic thresholds, 
and the relapses which we observed are not in 
favour of this hypothesis as they occurred at 
drug levels in the low-medium to medium 
range. The Italian study 6, where the results of 
drug treatment are good, required the plasma 
levels to be in the 'therapeutic', i.e. medium 
range. 
Second, drug treatment may fail due to non- 
compliance as patients after only a single seiz- 
ure may not take their situation seriously 
enough. This, however, can be ruled out as a 
cause in the present study where great pains 
were taken to make the patients aware of their 
condition. 
The third difficulty with drug treatment 
following a first seizure is the choice of drug. 
Many contemporary authors try to make us 
believe that there is practically no difference in 
the effectiveness ofthe major AEDs, at least in 
newly diagnosed cases. Our results do not con- 
firm this. Retrospectively, two medications of 
CBZ and DPH in photosensitve patients had to 
be abandoned ue to lack of effect. Prospec- 
tively, in patient 1, CBZ in the medium range 
did not prevent a seizure relapse in the 
presence of generalized spikes and waves, and 
in patient 3, VPA in the medium range simi- 
larly did not prevent a focal seizure relapse. 
For both patients who needed their cars for 
their jobs, these failures were most embarrass- 
ing. Although these are isolated findings, they 
cast methodological doubt on the above- 
mentioned studies whose designs would not 
have detected elayed failures like these where 
the relapses occurred beyond the first year of 
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follow-up, and the treatments would have been 
wrongly rated as successful. 
Our results, despite the comparatively few 
recurrent seizures, are in clear accord with the 
concept hat CBZ is the first choice drug for 
focal, and VPA for generalized seizures and 
photosensitivity. 
The principal message of this study however, 
is that the question which has been so long and 
fervently discussed, whether drug therapy 
should be started after a first seizure or not, is 
the wrong question to ask or, at best, is a 
question of marginal importance. There are 
situations (e.g. frequent EEG discharges, or a 
patient for whom an additional seizure could 
have catastrophic social consequences) where 
the doctor or the patient or both may feel better 
when a drug is prescribed, and hopefully no 
great harm is caused provided the patient 
takes the drug regularly (although serious ide 
effects may occur, there is always the ad- 
ditional risk of possible withdrawal seizures, 
and nobody knows how long such treatment 
should be continued, the correct drug and dose 
may be difficult to find, drug treatment prob- 
ably does not influence the prognosis very 
much, and drug treatment alone certainly 
gives far from satisfactory results). 
To reduce the risk of seizure relapse as much 
as possible, it seems to be much more worth- 
while to undertake a thorough analysis of all 
factors which may have contributed to the pre- 
cipitation of the first, rarely unprovoked, seiz- 
ure to make patients unmistakingly aware of 
the risks indicated by the event, and to teach 
them how they can avoid provocative factors in 
the future. Individually, this may be rather dif- 
ficult. The majority of patients are young, and 
this is often their first serious problem in life. 
Initially, it is difficult to accept and cope with, 
but quite a few of the patients reported here 
went into a second stage where they felt they 
had got control of the situation, and found they 
had become more mature during the process. 
During the prospective phase of this study, it 
has become increasingly clear to me that the 
printed memo 12 given to the patients, the 
repeated iscussion of the points included in it, 
and the participation of family members and 
friends in the talks are of invaluable import- 
ance. 
In the long run, some patients found their 
experiences as a consequence oftheir first seiz- 
ure to have changed their attitudes in such a 
way that they would rather not have missed it. 
Individually, a first seizure may be indicative 
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of a complex life crisis which needs an appro- 
priate approach, occasionally even including 
psychotherapy. 
According to Gowers 13, epilepsy may com- 
mence in one of three ways: with repetitive 
minor seizures which may long remain undiag- 
nosed; with severe fits recurring at short inter- 
vals; or 'with a single severe fit, and no other fit 
or sign of epilepsy for months and even years, 
when another attack occurs, after which they 
usually become frequent,' adding that the 
difference between the last two modes is grad- 
ual. Studies of first seizures mainly deal with 
the latter two modes, and very much seem to 
confirm Gower's view. 
Janz, when writing about epilepsy with 
grand mal on awakening 1°, notes that in these 
patients the seizures are usually provoked at 
least at the onset of the disease. Later, the pro- 
vocative factors often seem to lose importance. 
The treatment described here is obviously best 
suited to prevent the transition from single 
provoked seizures to those epilepsy syndromes 
where provoked seizures are common, and of 
which awakening grand mal epilepsy is a 
prototype. 
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